Literature DB >> 14980492

Hyperacetylation and differential deacetylation of histones H4 and H3 define two distinct classes of acetylated SV40 chromosomes early in infection.

Barry Milavetz1.   

Abstract

SV40 chromosomes undergoing encapsidation late in infection and SV40 chromatin in virions are hyperacetylated on histones H4 and H3. However, the fate of the SV40 chromosomes containing hyperacetylated histones in a subsequent round of infection has not been determined. In order to determine if SV40 chromosomes undergo changes in the extent of histone acetylation during early infection, we have analyzed SV40 chromosomes isolated 30 min and 3 h postinfection by quantitative ChIP assays, depletion ChIP assays, competitive ChIP assays, and ChIP assays combined with restriction endonuclease sensitivity using antibodies to hyperacetylated histones H4 and H3. We have shown that at 30 min postinfection, the hyperacetylated histones are associated with two distinct classes of SV40 chromosomes. One form is hyperacetylated specifically on histone H4 while a second form is hyperacetylated on both H4 and H3. Both forms of chromosomes appear to contain a nucleosome-free promoter region. Over the course of the next few hours of infection, the class of SV40 chromosomes hyperacetylated on only H4 is reduced or completely eliminated through deacetylation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980492     DOI: 10.1016/j.virol.2003.11.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Histone hyperacetylation in the coding region of chromatin undergoing transcription in SV40 minichromosomes is a dynamic process regulated directly by the presence of RNA polymerase II.

Authors:  Lata Balakrishnan; Barry Milavetz
Journal:  J Mol Biol       Date:  2006-09-20       Impact factor: 5.469

2.  Epigenetic Analysis of SV40 Minichromosomes.

Authors:  Lata Balakrishnan; Barry Milavetz
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

3.  Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome.

Authors:  Akira Nakanishi; Noriko Itoh; Peggy P Li; Hiroshi Handa; Robert C Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Histone hyperacetylation during SV40 transcription is regulated by p300 and RNA polymerase II translocation.

Authors:  Lata Balakrishnan; Barry Milavetz
Journal:  J Mol Biol       Date:  2007-07-03       Impact factor: 5.469

5.  P64, a novel major virion DNA-binding protein potentially involved in condensing the Spodoptera frugiperda Ascovirus 1a genome.

Authors:  Yeping Tan; Tatsinda Spears; Dennis K Bideshi; Jeffrey J Johnson; Robert Hice; Yves Bigot; Brian A Federici
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

6.  The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks.

Authors:  Gulshan Sunavala-Dossabhoy; Sri Kripa Balakrishnan; Siddhartha Sen; Sam Nuthalapaty; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2005-09-12       Impact factor: 2.946

7.  TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1.

Authors:  Siddhartha P Sen; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2006-10-20       Impact factor: 2.946

Review 8.  Epigenetic Regulation of Viral Biological Processes.

Authors:  Lata Balakrishnan; Barry Milavetz
Journal:  Viruses       Date:  2017-11-17       Impact factor: 5.048

9.  Ascovirus P64 Homologs: A Novel Family of Large Cationic Proteins That Condense Viral Genomic DNA for Encapsidation.

Authors:  Dennis K Bideshi; Tatsinda Spears; Heba A H Zaghloul; Yeping Tan; Yves Bigot; Brian A Federici
Journal:  Biology (Basel)       Date:  2018-09-11

Review 10.  Regulation of Polyomavirus Transcription by Viral and Cellular Factors.

Authors:  June F Yang; Jianxin You
Journal:  Viruses       Date:  2020-09-24       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.